Trends in on-label and off-label modafinil use in a nationally representative sample.

نویسندگان

  • Renée A Peñaloza
  • Urmimala Sarkar
  • David M Claman
  • Theodore A Omachi
چکیده

search, Department of Medicine, Baylor College of Medicine, Houston (Drs Singh, Petersen, and Sawhney); Department of Psychology, University of Houston, Houston (Dr Spitzmueller); and School of Biomedical Informatics and University of Texas–Memorial Hermann Center for Healthcare Quality and Safety, University of Texas Health Science Center at Houston (Dr Sittig). Correspondence: Dr Singh, Michael E. DeBakey Veterans Affairs Medical Center (152), 2002 Holcombe Blvd, Houston, TX 77030 ([email protected]). Author Contributions: Dr Singh had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Singh, Spitzmueller, Sawhney, and Sittig. Acquisition of data: Singh and Spitzmueller. Analysis and interpretation of data: Singh, Spitzmueller, Petersen, Sawhney, and Sittig. Drafting of the manuscript: Singh, Spitzmueller, and Sittig. Critical revision of the manuscript for important intellectual content: Singh, Spitzmueller, Petersen, Sawhney, and Sittig. Statistical analysis: Spitzmueller and Petersen. Obtained funding: Singh. Administrative, technical, and material support: Singh and Sittig. Study supervision: Singh and Sittig. Conflict of Interest Disclosures: None reported. Funding/Support: The research reported herein was supported by the Department of Veterans Affairs National Center for Patient Safety, a National Institutes of Health K23 career development award (K23CA125585) to Dr Singh and in part by the Houston VA Health Services Research and Development Center of Excellence (HFP90020). Dr Sittig is supported in part by a SHARP contract from the Office of the National Coordinator for Health Information Technology (ONC No. 10510592). Additional Contributions: We thank additional members of our project team, Donna Espadas, BS; Daniel Murphy, MD, MBA; Michael Smith, PhD; and Archana Laxmisan,MD,MA(allaffiliatedwiththeHoustonVAHealth ServicesResearchandDevelopmentCenterofExcellence), for theirvaluablecontributions to thesurvey.Noneof them received additional compensation for this work. Disclaimer: The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or any other funding agencies.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Trends in utilization and off-label use of polyethylene glycol 4000 laxatives and the prevalence of constipation in children in France

PURPOSE To determine trends in utilization and off-label use of polyethylene glycol (PEG) 4000 in children and to determine the prevalence of constipation. METHODS Retrospective cross-sectional analyses were conducted from 1997 to 2007 in a French health care database comprising general practitioners and pediatricians. Patients prescribed PEG 4000 (Forlax(®); Ipsen Pharma, Paris, France) were...

متن کامل

MLIFT: Enhancing Multi-label Classifier with Ensemble Feature Selection

Multi-label classification has gained significant attention during recent years, due to the increasing number of modern applications associated with multi-label data. Despite its short life, different approaches have been presented to solve the task of multi-label classification. LIFT is a multi-label classifier which utilizes a new strategy to multi-label learning by leveraging label-specific ...

متن کامل

Modafinil and armodafinil in schizophrenia.

What Might Be the Positive Spin-Offs Associated With Modafinil or Armodafinil Use in This Patient? Racemic modafinil and its R-isomer armodafinil are approved treatments for the excessive daytime drowsiness associated with narcolepsy, shift work, and obstructive sleep apnea1; therefore, either of these drugs could benefit Mr P. In schizophrenia, modafinil and armodafinil have been prescribed, s...

متن کامل

Review Study: Intravenous Thrombolysis, Time Window, Dosage, and Off-Label

Despite the development of Intravenous thrombolysis with tissue Plasminogen Activator (IVtPA) guidelines in each affiliated stroke center, protocol violations may be observed in each hospital with IVtPA facilities. An extensive search of scientific electronic databases including PubMed, OVID, Index Medicus, Index Copernicus, Google, ISI, and Scopus was performed with keywords of Thrombolysis, O...

متن کامل

Utilization of Modafinil in Oregon Fee-For-Service Patients

Modafinil (Provigil) is a medication used to promote wakefulness. Originally marketed in 1998, modafinil, a Schedule C-IV drug, was approved by the Food and Drug Administration (FDA) for the treatment of excessive sleepiness (ES) associated with narcolepsy. In 2003, the FDA approved modafinil for the treatment of ES associated with obstructive sleep apnea-hypopnea syndrome (only as an adjunct t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • JAMA internal medicine

دوره 173 8  شماره 

صفحات  -

تاریخ انتشار 2013